ARCHIVES

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

(8-page issue).

January 31, 2003

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Southwest, Children’s Cooperative Groups Get Cancer To Extend Research Into Community Hospitals

October 8, 1976

BSA Working Group

November 12, 2010

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975